According to the research report titled ‘Global Clinical Trial Kits Market 2022-2028’, available with MarketStudyReport, global clinical trial kits market is expected to register a CAGR of 7.4% through 2028, hence witnessing a surge of USD 327 million in the value by the forecast period end.

The expansion of global clinical trial kits industry is backed by growing geriatric population, increasing R&D activities with preference for outsourcing services, adoption of advanced technologies in clinical research, and rising incidences of chronic ailments.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/5042714/

Furthermore, surge in demand for remote clinical trial facilities, rising investments by governmental bodies in healthcare research, and the immense popularity of home diagnostic services are also leading to market growth.

Besides a comprehensive overview of growth drivers and potential scenarios, the study also evaluates the restraints and bottlenecks present in the industry sphere, along with the plausible solutions that will assist stakeholders in sustaining better profits.

On top of that, the research also delivers a detailed analysis of market size, key trends, competitive landscape, growth rate, and sub-segmentations. It also mentions the impact of the COVID-19 outbreak on the global clinical trial kits industry growth.

Speaking of product type, the market segmentation consists of sample collection kits and drug kits. Based on the phases, the industry is bifurcated into phase IV, phase III, phase II, and phase I. While various regions studied are Middle East & Africa, Asia Pacific, South America, Europe, and North America.

At the close, the research also provides extensive information on the competitive hierarchy of the market, while thoroughly dissecting agreements, partnerships, collaborations, and mergers & acquisitions.

The top-notch players responsible for higher revenue inflow and growth of worldwide clinical trial kits industry are Thermo Fisher Scientific Inc., Precision Medicine Group LLC, Laboratory Corporation of America Holdings (Labcorp), Clinigen Ltd. (Clinigen Group), Cerba Research, Alpha Laboratories Ltd., Q2 Solutions LLC (IQVIA Holdings Inc.), Marken Limited, LabConnect LLC, Charles River Laboratories International Inc., Azenta US Inc., and Almac Group Limited.